euphorbiafactor L2
CAS No. 218916-51-9
euphorbiafactor L2( —— )
Catalog No. M20416 CAS No. 218916-51-9
Euphorbiafactor L2 alleviates lipopolysaccharide-induced acute lung injury and inflammation through inhibits NF-κB activation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 216 | In Stock |
|
| 5MG | 150 | In Stock |
|
| 10MG | 217 | In Stock |
|
| 25MG | 370 | In Stock |
|
| 50MG | 532 | In Stock |
|
| 100MG | 756 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Nameeuphorbiafactor L2
-
NoteResearch use only, not for human use.
-
Brief DescriptionEuphorbiafactor L2 alleviates lipopolysaccharide-induced acute lung injury and inflammation through inhibits NF-κB activation.
-
DescriptionEuphorbiafactor L2 alleviates lipopolysaccharide-induced acute lung injury and inflammation through inhibits NF-κB activation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetNF-κB
-
RecptorNF-κB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number218916-51-9
-
Formula Weight642.7
-
Molecular FormulaC38H42O9??
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 83.33 mg/mL (129.65 mM)
-
SMILES[H][C@]12C[C@@H](OC(=O)c3ccccc3)C(=C)[C@H](OC(C)=O)[C@@]3([H])[C@@H](OC(=O)c4ccccc4)[C@@H](C)C[C@]3(OC(C)=O)C(=O)\C(C)=C/[C@@]1([H])C2(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Qiuping Z Shuai Z Xiaolan C et al. Euphorbia factor L2 alleviates lipopolysaccharide-induced acute lung injury and inflammation in mice through the suppression of NF-κB activation[J]. Biochemical Pharmacology 2018 155:444-454.
molnova catalog
related products
-
Phyllanthin
Phyllanthin is widely used as hepatoprotective and antigenotoxic and inhibit function of P-gp.
-
Sodium Houttuyfonate
Sodium Houttuyfonate, the active compound of the Houttuynia plant, is mainly used for treating purulent skin infections, respiratory tract infections, including pneumonia in elderly patients, and chronic bronchitis.
-
Tomatidine
Tomatidine decreases inducible NO synthase and COX-2 expression through suppression of I-κBα phosphorylation, NF-κB nuclear translocation and JNK activation, which in turn inhibits c-jun phosphorylation and Oct-2 expression.
Cart
sales@molnova.com